Engflag

Hycort

Quick links to important sections

Hycort

Hycort_EN

Method of action: Antiallergic, Antiexudative, Antihemorrhoidal, Anti-Inflammatory, Antipruritic, Anti-Shock, Corticosteroids For Systemic Use, Corticosteroids, Dermatological Preparations, Desensitizing, Glucocorticoid

Treatment option: Addison's Disease, Allergic Conjunctivitis, Anaphylaxis, Anemia, Ankylosing Spondylitis, Arthritis,Osteoarthritis, Asthma, Atopic Dermatitis, Berylliosis, Crohn'S Disease

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hycort

Property Description
Active Ingredient Hydrocortisone
Form Tablet, Injection, Cream, Ointment (Systemic and Topical)
Pharmacological Class Glucocorticoid (Corticosteroid)
Common Use Anti-inflammatory and Hormonal Replacement
Origin Synthetic derivative of Cortisol

What Kind of Medication is Hycort?

Hycort is a prescription-only medicine whose fundamental active ingredient is Hydrocortisone, a powerful anti-inflammatory substance. This compound is classified as a Corticosteroid, specifically within the category of Glucocorticoids. Hydrocortisone is technically the pharmaceutical term for Cortisol, the primary endogenous hormone naturally secreted by the human adrenal cortex, which regulates vital metabolic and immunologic functions. Hydrocortisone is often used because it is chemically identical to the natural hormone, making it ideal for replacement therapy, a practice for managing endocrine disorders. Hycort is thus a synthetic derivative used to mimic these essential hormonal actions.

Composition, Types, and General Purpose

The core composition of Hycort is the Hydrocortisone molecule combined with various inert bases, allowing for multiple applications. The medication is prepared in diverse dosage forms for both systemic and topical administration, including tablets for oral use, injectable solutions for internal delivery, and semi-solid bases like creams and ointments for localized application. Corticosteroids are essential medicines due to their ability to provide potent suppression of inflammation across various body systems. The drug’s overarching general purpose is derived from its pharmacological class: it serves as an effective agent for the suppression of inflammation and modulation of immune activity, and crucially, functions as necessary hormonal replacement therapy in patients with states of adrenocortical insufficiency.

Regulatory References

  1. MedlinePlus

What side effects are possible with Hycort?

Possible Side Effects and Safety Information

The safety profile of Hycort (hydrocortisone) is comprehensively defined in regulatory documents based on its classification as a systemic glucocorticoid. The majority of documented adverse reactions are directly related to the medicine's core hormonal action and are often classified across various System-Organ Classes (SOCs).

Officially Documented Adverse Reactions

The adverse effects are extensive, covering systems such as Metabolism and Nutrition (e.g., fluid retention, potassium loss) and Musculoskeletal (e.g., muscle weakness, osteoporosis). Other commonly cited effects in regulatory labeling include Gastrointestinal Disorders (peptic ulceration), Endocrine Disorders (Cushingoid state), and Psychiatric Disturbances (e.g., mood changes, insomnia).

Serious and Exposure-Related Safety Patterns

A specific tier of Serious Adverse Reactions is documented, including the risk of adrenal crisis or acute adrenocortical insufficiency upon abrupt cessation of treatment. The risk for many systemic effects, such as cataracts and severe osteoporosis, is explicitly linked in official sources to long-term exposure at higher doses. This time-dependent pattern helps structure the understanding of the medicine's risk profile.

Special Safety Considerations

Official labeling includes specific notes for certain patient populations. For the pediatric population, there is a documented risk of growth suppression. Additionally, use is generally restricted in patients with systemic fungal infections (a formal contraindication). Caution is required for individuals with pre-existing conditions that may be aggravated, such as hypertension or diabetes mellitus.

Overdose and Emergency Response

Hycort Overdose and When to Seek Help

Official regulatory documents define hydrocortisone overexposure primarily through its acute effects on physiological balance. Documented clinical manifestations can include elevation of blood pressure, notable salt and water retention, and increased excretion of potassium. Other serious signs noted in labeling involve the nervous system, such as convulsions (seizures), altered mental status, and heart rhythm disturbances.

Emergency Actions Mandated by Regulators:

Immediate medical help must be sought for suspected overexposure. You must immediately call emergency services if the affected person has collapsed, is experiencing a seizure, or has trouble breathing. You are also instructed to call the poison control helpline right away.

The official labeling states that no specific antidote is known for hydrocortisone overdose. Treatment in a clinical setting is symptomatic and supportive, focusing on continuous monitoring of vital signs, including the use of an ECG and blood tests, to correct fluid and electrolyte imbalances. It is noted in official prescribing information that pediatric patients may be more susceptible to systemic toxicity, especially from excessive topical use.

Therapeutic Uses of Hycort

Quick Facts: Therapeutic Domains

  • May be used in the management of allergic conditions.
  • Intended for use in certain skin disorders and inflammatory issues.
  • May be prescribed to help address rheumatic conditions.

Hycort (hydrocortisone) is an approved medication used in the management of a diverse range of conditions where it can provide relief from inflammation and immune response symptoms. This medication is commonly prescribed to address disorders affecting the joints and soft tissues, such as certain types of arthritis, and for temporary use during acute exacerbations of rheumatic conditions.

In the dermatologic domain, Hycort may be used to help reduce the inflammatory and itching symptoms associated with various skin disorders, including atopic dermatitis and severe forms of psoriasis. The drug is also used to help control severe or incapacitating allergic conditions that have not adequately responded to conventional treatments. Additionally, it may be used for patients with conditions like ulcerative colitis and certain respiratory, ocular, and hematologic disorders. Its therapeutic action is aimed at reducing swelling and modifying the body's immune processes to help resolve symptoms.

Physicians may prescribe this medication to manage conditions related to low levels of natural corticosteroids (adrenocortical insufficiency).

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Hycort — Official Regulatory Information

Populations for whom use is contraindicated:

  • Patients with known hypersensitivity to hydrocortisone or any component of the formulation.
  • Individuals with Systemic Fungal Infections (for systemic use).
  • Patients receiving immunosuppressive doses of the medicine who are scheduled to receive live or live, attenuated vaccines.

Age-related eligibility rules:

  • Adults are the standard population for use.
  • Pediatric Use: Use is established, but prolonged systemic administration may lead to growth retardation. The patient’s growth must be monitored.
  • Older Adults: Use is permitted, but caution is necessary due to the potentially more serious consequences of common side effects in this age group.

Condition-specific and Reproductive Restrictions:

  • Caution is required in patients with pre-existing conditions such as diabetes mellitus (due to hyperglycemia risk), hypertension, congestive heart failure (due to fluid retention), and peptic ulcers.
  • Pregnancy Status: The medicine is generally classified to require weighing the potential benefit against the potential risk to the fetus, as hydrocortisone readily crosses the placenta.
  • Lactation Status: Systemic corticosteroids are excreted in breast milk. Mothers taking pharmacological doses are generally advised not to breastfeed due to the potential for infant adrenal suppression.

Eligibility classifications (high-level)

Classification Population/Condition
Contraindicated Systemic Fungal Infection, Hypersensitivity
Use with Caution Diabetes, Congestive Heart Failure, Latent Tuberculosis, Geriatric Age
Not Recommended Breastfeeding (with systemic pharmacological doses)

What should I know about interactions with other medicines?

Interactions with other medicines and products

Hydrocortisone, the active ingredient in Hycort, is subject to officially documented interactions that modify its systemic exposure or amplify certain physiological effects, as noted in government regulatory labeling. All interaction information below is strictly descriptive and non-advisory.

Formal Interaction Restrictions

Category Interacting Agent Official Interaction Outcome / Restriction
Contraindicated Live/Attenuated Vaccines Prohibited when receiving immunosuppressive doses of hydrocortisone.
Contraindicated Systemic Fungal Infections Use of hydrocortisone is prohibited in the presence of these infections.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interaction Type Interacting Agent Official Regulatory Statement
Metabolic CYP3A4 Inhibitors (e.g., ketoconazole) Increased systemic exposure of hydrocortisone due to decreased metabolism.
Metabolic CYP3A4 Inducers (e.g., rifampicin, phenytoin) Increased clearance of hydrocortisone, potentially leading to reduced systemic exposure.
Pharmacodynamic Potassium-Depleting Agents (e.g., diuretics) Enhanced risk of potassium loss and hypokalemia.
Pharmacodynamic Antidiabetic Agents Hydrocortisone may antagonize the therapeutic effects of the antidiabetic medicine.

Food and Substance Interaction Notes:

Consumption of Grapefruit Juice is officially documented to inhibit the metabolism of hydrocortisone, which can result in increased blood levels. Estrogens, including those in oral contraceptives, are noted to reduce the metabolism of hydrocortisone, increasing its exposure and half-life.

Mechanism of Action

Hycort (hydrocortisone) functions as a glucocorticoid receptor (GR) agonist to modulate key cellular and systemic pathways.

Its primary action involves ligand binding to the cytosolic GR, forming a complex that translocates to the cell nucleus. This complex modifies gene transcription through transrepression (suppressing transcription factors such as NF-kappa B) and transactivation (inducing genes like Lipocortin-1/Annexin A1). This sequence regulates the transcription of genes associated with immune and inflammatory signaling pathways.

Downstream, the induced protein Lipocortin-1 inhibits the enzyme phospholipase A2 ( PLA2), which catalyzes the release of arachidonic acid. By restricting this early molecular step, Hycort limits the production of eicosanoid mediators, including prostaglandins and leukotrienes.

Additionally, Hycort alters the functionality and location of immune cells, promoting the programmed death (apoptosis) of specific cell subsets and modulating the localized release of pre-formed mediators from macrophages and mast cells.

Dosage and Administration Information

Hycort (hydrocortisone) administration is determined by its formulation, therapeutic goals, and the patient's clinical state. The medicine is administered via Oral route (tablet or granule), Intravenous (IV) injection/infusion, Intramuscular (IM) injection, or Topically.

Official Dosing and Administration Schedules

Administration Type Dosing Schedule Principle
Systemic Oral Maintenance Daily dose is typically 15 mg to 25 mg, administered in 2 to 3 divided doses to mimic natural hormone release.
Acute/High-Dose IV Initial dose is 100 mg IV/IM, which may be repeated at 2, 4, or 6 hour intervals. High-dose therapy should generally not continue beyond 48 to 72 hours.
Pediatric Dosing Dose is determined by Body Surface Area (BSA), typically 8 mg/m² to 10 mg/m² daily, given in divided doses.

Administration Requirements: Immediate-release tablets may be taken with or without food. However, modified-release tablets must be swallowed whole (do not crush or chew) and taken at least 30 minutes before food. Powder for injection must be reconstituted with sterile water before IV or IM use.

Procedural Constraints: The dose must be temporarily increased during periods of acute physical or mental stress, such as fever or surgery. Following prolonged systemic use, the dose must be gradually tapered over time to discontinue the medication.

Recent Clinical Evidence

Hycort: Recent Clinical Evidence

Early-Phase Clinical Studies

Early-phase studies explored patient-reported outcomes related to pain and mobility in subjects with inflammatory joint conditions. These trials primarily served to establish initial safety and tolerability.

  • Study Design: These were small, randomized, double-blind trials.
  • Key Finding: Research has also included assessments of the time point at which changes in joint discomfort were reported.

Long-Term Research in Osteoarthritis

Studies have investigated the relationship between observed changes in swelling and patient-reported measures of joint function in chronic arthritis. Trials focused primarily on individuals with mild-to-moderate arthritis, and included subjects with chronic knee osteoarthritis.

  • Dose Response: Trials examined whether differing doses were associated with changes in patient-reported joint stiffness and quality of life.
  • Safety Profile: Safety and tolerability measures were monitored in the initial cohort, but formal patient eligibility was strictly defined by trial protocols.

Combination Therapy Trials

Clinical research has also examined the use of Hycort in combination with other substances. The combination of ingredients A, B, and C was evaluated in studies focusing on biomarkers and radiographic changes associated with joint structure.

One clinical study reported differences in changes in joint space width compared to placebo, as measured via X-ray images.

  • Patient Population: Trials included subjects with confirmed mild-to-moderate knee and hip osteoarthritis, excluding patients with advanced-stage joint disease.
  • Follow-up Duration: Research evaluated outcomes over periods ranging from six to twelve months.

Frequently Asked Questions (FAQ)

Common questions about Hycort (FAQ)

Q: What is Hycort used for?

A: Hycort is officially indicated for the treatment of various conditions where immunosuppression and anti-inflammatory effects are required. These conditions often relate to endocrine disorders, rheumatic diseases, and specific allergic or dermatologic states. Official product information states that it works to reduce inflammation and modify the body's immune response.

Q: How should I store Hycort?

A: According to the official product information, Hycort should be stored at room temperature, specifically between 20 C and 25 C (68 F and 77 F). It is important to keep the medication in its original container, protected from moisture and heat. The medication should also be kept out of the reach of children.

Q: Is it safe to drink alcohol while taking Hycort?

A: Regulatory documents do not contain specific warnings or contraindications regarding the consumption of alcohol while taking Hycort. Patients are generally advised to discuss alcohol consumption with a healthcare provider. The potential interaction of alcohol with Hycort and its effects on the body should be reviewed with a medical professional.

Q: What is the active ingredient in Hycort?

A: The official product information confirms that the active ingredient in Hycort is hydrocortisone. Hydrocortisone is a type of corticosteroid, which is a class of medications used to reduce inflammation and modify the immune system. The other components are listed as inactive ingredients, or excipients.

Q: Can Hycort cause problems with my eyes?

A: Studies and official information indicate that Hycort, as a corticosteroid, may potentially be associated with certain ocular (eye-related) issues. Long-term use of corticosteroids has, in some cases, been linked to conditions such as cataracts or glaucoma (increased pressure in the eye). Monitoring by an eye care specialist may be suggested by a prescriber, especially during extended courses of treatment.

Q: Can I stop taking Hycort suddenly?

A: Regulatory documents strongly advise against suddenly stopping Hycort, especially after taking it for a prolonged period. Abrupt discontinuation can lead to withdrawal symptoms or a return of the condition being treated. Official prescribing information advises that any decision to stop the medication should be done through a gradual reduction plan overseen by a healthcare professional.

Q: Can Hycort affect blood sugar levels?

A: According to the official product information, Hycort can affect blood sugar levels because it is a corticosteroid. This may be of particular concern for people with diabetes, as it can potentially cause hyperglycemia (high blood sugar). For individuals with diabetes, blood sugar monitoring may need to be adjusted during treatment, as indicated by a healthcare provider.

How should Hycort be stored and disposed of?

How to Store and Dispose of Hycort

Official regulatory guidelines define specific conditions for storing and disposing of Hycort (hydrocortisone) to maintain product stability.

Storage Requirements

Most Hycort formulations, including tablets, creams, and the unreconstituted injection powder, must be stored at controlled room temperature (20 C to 25 C / 68 F to 77 F). The reconstituted injection solution must not be frozen and must be protected from light. Stability after mixing is limited, often requiring use within 12 to 24 hours.

Disposal and Child Safety

All Hycort products must be stored out of the reach of children. Unused or expired medication should be disposed of according to local requirements, typically through drug take-back programs. Used needles and syringes from injection kits must be discarded in compliance with local and federal sharps regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagCanada

flagPhilippines

flagUSA

Equivalent of Hycort found in:

A-Z Index: